OpenFilings

Cidara Therapeutics, Inc.

Form10-K

Report Period2023-12-31

Date Filed2024-04-22

Time Filed16:56:44

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

CIDARA THERAPEUTICS, INC. 2023 FORM 10-K
CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION
AMENDED AND RESTATED NON-EMPLOYEE DIRECTOR COMPENSATION POLICY
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934
CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002
CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002
INCENTIVE COMPENSATION RECOUPMENT POLICY
Filing on SEC Edgar